Indian Journal of Paediatric Dermatology

CME ARTICLE
Year
: 2019  |  Volume : 20  |  Issue : 1  |  Page : 1--4

Atopic dermatitis: Update on comorbidities and therapeutic advances


Katie Kim1, Caitlin Crimp2, Robert Sidbury3 
1 Pacific Northwest University of Health Sciences, Yakima, WA, USA
2 University of Washington School of Medicine, Seattle, WA, USA
3 University of Washington School of Medicine; Department of Pediatrics, Division of Dermatology, Seattle Children's Hospital, University of Washington School of Medicine, Seattle, WA, USA

Correspondence Address:
Prof. Robert Sidbury
Department of Pediatrics, Division of Dermatology, Seattle Childrenfs Hospital, University of Washington School of Medicine, Seattle, WA 98105
USA

Atopic dermatitis (AD) is a chronic inflammatory disorder that primarily affects the skin. Recent literature has expanded our knowledge of associated comorbidities. In this review, we will discuss sleep loss, attention deficit hyperactivity disorder, obesity, and anemia as they relate to AD. We will also review two recently approved medications and how they fit into the therapeutic ladder.


How to cite this article:
Kim K, Crimp C, Sidbury R. Atopic dermatitis: Update on comorbidities and therapeutic advances.Indian J Paediatr Dermatol 2019;20:1-4


How to cite this URL:
Kim K, Crimp C, Sidbury R. Atopic dermatitis: Update on comorbidities and therapeutic advances. Indian J Paediatr Dermatol [serial online] 2019 [cited 2019 Feb 19 ];20:1-4
Available from: http://www.ijpd.in/article.asp?issn=2319-7250;year=2019;volume=20;issue=1;spage=1;epage=4;aulast=Kim;type=0